Featured Products

About Izun

Izun Pharmaceuticals Corp. is an emerging biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments.

Recent News

  • Izun Pharmaceuticals Corp Appoints Jack Talley as Chief Executive Officer Izun Pharmaceuticals Corporation (“Izun”, izunpharma.com), a clinical stage company focused on developing high efficacy products based on compounds derived from botanical sources announced today that it has appointed Jack Talley as its Chief Executive Officer.   Mr. Talley brings over 30 years of relevant experience in the pharmaceutical industry, fifteen of which were as CEO
    July 22, 2015 plus
  • CannRx Technology Partner Receives ISO 17025 Certification for Its Laboratory CannRx Technology, Inc. (“CannRx”, www.cannrx.com), a privately-held Delaware corporation whose mission is to develop high quality pharmaceutical products from cannabis by leveraging its patented technology, announced today that its partner Izun Pharma Limited (“Izun”, www.izunpharma.com) has been awarded ISO 17025 certification for the analysis  of cannabis and cannabis-based products. The certification of Izun represents the
    April 22, 2015 plus

We would love to be in touch with you

  • This field is for validation purposes and should be left unchanged.